Powerful study management updates provide cutting-edge digital pathology capabilities.
Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.
Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.
New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)
New powerful technology and data sharing suite provides a range of translational science solutions
New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety
